YOLFTbeta
Enseval Putra Megatrading Tbk

Enseval Putra Megatrading Tbk

EPMT · JK · Healthcare / Medical Distribution

2,360.00IDR+50.00 (+2.16%)

Price History

Full chart

Market Stats

Previous Close2,310.00
Open2,320.00
Day Range2,320.00 – 2,380.00
52-Week Range2,090.00 – 2,900.00
Volume800
Market Cap7.18T
P/E (TTM)8.66
Forward P/E12.87
EPS306.08
Dividend Yield0.00%
Beta-0.00
50-Day Avg2,444.60
200-Day Avg2,352.15

About

PT Enseval Putera Megatrading Tbk., together with its subsidiaries, engages in the distribution and supply of pharmaceutical products, consumer products, medical equipment, cosmetics, and other trading products in Indonesia. The company operates through three segments: Pharmaceutical, Consumer Products, and Others. It also trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, consumable products for hemodialysis therapy, pharmaceutical, medical equipment, and food and beverage; prescription and non-prescription medicines; veterinary products; and operates drug stores, health care clinics, and hemodialysis clinic. In addition, the company provides dental and other equipment; calibration services; distribution and logistics for consumer goods that require cold room temperature handling; transportation and warehousing service using digital platform; information services through web portals and/or digital platforms; healthcare services; end-to-end value added services; and logistic services, including chiller, cool, and ambient rooms, as well as container chiller. Further, it offers EMOS, a business-to-business (B2B) platform that offers pharmaceuticals and consumer health products; and MOSTRANS, an intelligent logistics platform that connects with shippers, transporters, and receivers. The company was formerly known as PT Arya Gupta Cempaka and changed its name to PT Enseval Putera Megatrading Tbk. in August 1993. PT Enseval Putera Megatrading Tbk. was founded in 1973 and is headquartered in Jakarta Timur, Indonesia. PT Enseval Putera Megatrading Tbk. is a subsidiary of PT Kalbe Farma Tbk.

Company Details

  • SectorHealthcare
  • IndustryMedical Distribution
  • CEOMr. Jos Iwan Atmadjaja
  • Employees5.10K
  • HeadquartersJl. Pulo Lentut No. 10, Jakarta Timur, Indonesia, 13920, Indonesia
  • Websitehttps://www.enseval.com

Leadership

  • Mr. Jos Iwan AtmadjajaPresident Director · b. 1970
  • Johannes BajuFinance Director
  • Mr. Handi HalimIT, Operation & Legal Director · b. 1966
  • Mr. . SugiantoCorporate Secretary, Legal & Investor Relations Manager · b. 1979
  • Kusnadi AlimHead of Sales
  • Medianto Henky SaputraHead of Human Resources & General Affair
  • Mr. Djonny Hartono TjahyadiHead of Digital Business & Medical Devices · b. 1964
  • Mr. Stanley Handiono AngkasaSupply Chain Management Director & Director · b. 1976
  • Mr. Taruna WidjajaHead of Medical Devices & Subsidiary Director
  • Mr. Rustam TanHead of Internal Audit Division · b. 1970

Financials

Income Statement

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue1.65T2.06T3.18T3.82T4.50T5.32T5.52T6.37T7.39T8.55T9.71T10.61T13.37T15.62T17.01T17.48T18.94T19.67T20.60T22.23T22.55T25.67T28.03T28.51T30.96T32.96T
Growth (%)-+24.99%+54.07%+20.05%+17.80%+18.40%+3.72%+15.30%+16.10%+15.66%+13.61%+9.23%+26.04%+16.83%+8.89%+2.73%+8.36%+3.87%+4.76%+7.87%+1.43%+13.88%+9.17%+1.71%+8.59%+6.47%
Cost of Revenue1.45T1.78T2.74T3.32T3.94T4.67T4.80T5.56T6.46T7.42T8.62T9.40T11.94T13.86T15.08T15.37T16.76T17.53T18.21T19.77T20.09T22.87T25.06T25.59T27.89T29.85T
Gross Profit-----------1.21T1.44T1.76T1.93T2.11T2.18T2.13T2.40T2.45T2.46T2.81T2.96T2.91T3.07T3.11T
Gross Margin-----------11.40%10.74%11.29%11.34%12.07%11.50%10.85%11.63%11.04%10.91%10.93%10.58%10.22%9.92%9.43%
Operating Expense-----------740.33B899.58B1.15T1.26T1.37T1.43T1.45T1.52T1.65T1.63T1.75T1.88T2.01T2.09T2.11T
Operating Income93.97B144.30B179.77B197.16B243.91B281.53B271.42B307.18B363.10B484.36B360.85B469.02B536.83B616.92B667.56B737.38B752.20B684.88B873.91B802.25B826.74B1.05T1.08T905.25B984.32B995.63B
Operating Margin5.69%6.99%5.65%5.17%5.42%5.29%4.91%4.82%4.91%5.66%3.71%4.42%4.01%3.95%3.92%4.22%3.97%3.48%4.24%3.61%3.67%4.09%3.87%3.18%3.18%3.02%
EBITDA-----------539.87B629.85B732.04B782.78B866.46B883.13B765.14B962.10B935.66B1.04T1.27T1.28T1.07T1.15T1.19T
EBITDA Margin-----------5.09%4.71%4.69%4.60%4.96%4.66%3.89%4.67%4.21%4.61%4.96%4.57%3.76%3.73%3.61%
Net Income-54.41B122.42B156.33B179.26B203.30B209.16B231.65B266.89B329.07B257.42B351.04B402.75B464.32B510.61B547.12B556.03B517.67B653.06B580.63B680.60B847.88B847.53B688.50B741.77B789.19B
Net Income Margin-2.64%3.85%4.10%3.99%3.82%3.79%3.64%3.61%3.85%2.65%3.31%3.01%2.97%3.00%3.13%2.94%2.63%3.17%2.61%3.02%3.30%3.02%2.42%2.40%2.39%
R&D---------------3.29B1.29B1.01B4.77B2.43B2.66B1.97B2.07B2.62B4.31B5.99B
R&D as % of Total Revenue---------------0.02%0.01%0.01%0.02%0.01%0.01%0.01%0.01%0.01%0.01%0.02%
Interest Expense000000000008.42B9.33B13.28B15.43B13.04B10.76B9.92B5.39B6.16B10.85B10.10B10.79B20.75B23.66B21.01B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.08%0.07%0.08%0.09%0.07%0.06%0.05%0.03%0.03%0.05%0.04%0.04%0.07%0.08%0.06%

Balance Sheet

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets819.62B896.59B1.10T1.32T1.65T1.86T1.81T2.09T2.51T2.99T3.25T4.37T4.95T5.53T6.19T6.75T7.09T7.43T8.32T8.70T9.21T9.73T10.40T10.96T11.49T13.13T
Total Liabilities745.08B767.26B845.48B921.27B1.08T1.09T862.31B967.28B1.18T1.38T1.46T1.94T2.37T2.49T2.64T2.68T2.47T2.30T2.54T2.58T2.65T2.88T3.26T3.66T3.91T5.27T
Total Equity74.01B128.68B250.90B398.05B574.16B763.70B952.49B1.13T1.34T1.60T1.80T2.43T2.58T3.04T3.55T4.07T4.62T5.13T5.79T6.13T6.54T6.83T7.11T7.25T7.53T7.82T
Cash22.83B22.35B132.90B7.05B114.01B106.08B235.34B133.94B347.73B270.22B244.98B760.66B825.60B405.18B717.10B1.13T1.22T811.49B1.26T1.04T1.62T1.32T987.73B686.20B687.66B712.02B
Total Debt----------24.29B28.84B87.71B120.46B113.74B144.29B41.68B--44.15B26.17B13.05B118.71B140.09B220.80B8.43B
Net Debt-----------220.69B-731.82B-737.90B-284.72B-603.35B-984.81B-1.18T-811.49B-1.26T-997.09B-1.59T-1.31T-869.03B-546.11B-466.85B-703.59B

Cash Flow

Currency: IDR2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow40.54B88.84B51.20B136.09B26.89B154.38B206.72B4.89B254.76B71.15B213.36B68.71B80.50B95.98B115.22B129.08B126.75B120.75B127.26B248.92B980.70B404.81B847.53B398.83B659.88B826.51B
Investing Cash Flow12.19B-----185.29B-----156.32B-85.46B-258.48B-183.19B-196.79B-31.74B-137.44B-76.29B-262.86B-156.53B-133.80B139.91B-180.54B-257.13B-287.24B
Financing Cash Flow--23.21B--------286.73B-235.07B-1.37B-40.29B-27.70B-114.11B-23.47B-18.96B-249.96B-246.89B-566.18B-450.82B-530.14B-402.45B-516.73B
Capital Expenditure9.26B12.82B31.27B42.07B58.74B71.15B87.04B69.30B84.89B110.61B148.38B157.61B171.08B272.10B215.14B180.75B96.57B199.06B128.21B315.30B230.95B115.46B129.68B187.49B213.44B227.14B
Free Cash Flow------------88.90B-90.58B-176.12B-99.93B-51.66B30.18B-78.31B-954.39M-66.38B749.75B289.35B717.85B219.19B446.44B599.37B
Dividends Paid4.56B----11.40B11.40B57.00B57.00B62.70B62.70B12.43B236.09B5.42B-13.54B13.54B13.54B13.57B243.78B243.78B541.73B555.27B555.27B449.63B485.13B
FCF to OCF------------129.39%-112.53%-183.50%-86.73%-40.02%23.81%-64.86%-0.75%-26.67%76.45%71.48%84.70%54.96%67.65%72.52%
Dividend Paid to FCF------------13.98%-260.63%-3.08%--26.21%44.87%-17.29%-1421.66%-367.25%32.51%187.22%77.35%253.33%100.71%80.94%

Earnings

Report DateApr 30, 2007May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 31, 2016Apr 29, 2016Jul 29, 2016Nov 1, 2016Mar 30, 2017Apr 28, 2017Aug 1, 2017Oct 31, 2017Mar 29, 2018Apr 26, 2018Aug 29, 2018Nov 28, 2018Feb 27, 2019Apr 25, 2019Aug 28, 2019Nov 27, 2019Feb 26, 2020Apr 30, 2020Sep 2, 2020Oct 27, 2020Apr 29, 2021Jul 30, 2021Oct 25, 2021Apr 28, 2022Jul 29, 2022Nov 1, 2022Mar 30, 2023Apr 28, 2023Jul 31, 2023
EPS Estimate23.00------------------------------------
EPS Actual23.0031.6949.2350.1557.4535.2448.2159.9058.6545.4951.5342.1866.0933.2456.8634.5766.4542.3962.5668.3567.8048.7667.2457.8640.4964.9253.9842.2085.5567.7396.1297.2462.9287.7265.0299.8028.03
Surprise0.00%------------------------------------
TimingPre-market-------After-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market--------------------

Key Statistics & Ratios

Market Cap7.18T
Enterprise Value6.70T
Trailing P/E8.66
Forward P/E12.87
Price / Sales0.20
Price / Book0.86
EPS306.08
Book Value3,048.42
Revenue (TTM)35.18T
Gross Profit (TTM)3.44T
EBITDA1.31T
Profit Margin2.36%
Operating Margin2.68%
Return on Equity10.54%
Return on Assets5.31%
Shares Outstanding2.71B
Shares Float210.71M
Beta-0.00
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20251×
179.00Jun 3, 2025
20241×
166.00May 27, 2024
20231×
205.00May 11, 2023
20221×
205.00May 27, 2022
20211×
200.00Jun 2, 2021
20201×
90.00May 15, 2020
20191×
90.00May 28, 2019
20181×
5.00May 23, 2018
20171×
5.00Jun 2, 2017
20161×
5.00Jun 2, 2016
20151×
5.00May 19, 2015
20131×
2.00Jun 17, 2013
20121×
95.00Jun 8, 2012
20111×
5.00Jul 11, 2011
20101×
27.16Jul 6, 2010
20091×
27.16Jul 3, 2009
20081×
24.69Jul 18, 2008
20071×
24.69Jun 29, 2007
20061×
4.94Aug 16, 2006